Research Interests
Open to PhD applications in the field of nano-drug delivery, biopharmaceutics, nucleic acid therapies and ex vivo cellular therapies.
- Development of nanomedicines for cancer and neurological diseases
- Design of non-viral delivery systems
- Delivery of nucleic acids (mRNA, siRNA, ASOs, etc)
Public outreach & key achievements
Recent articles:
- 1016/j.jconrel.2020.11.037
- https://doi.org/10.1016/j.ijpharm.2021.120223
- https://doi.org/10.1186/s12951-021-00856-x
- https://doi.org/10.1016/j.ijpharm.2021.120366
Research students
PhD Title | Non-viral Genetic Engineering of Immune Effector Cells for CAR therapies |
Name | Ciaran McGranaghan |
Years of Study | 2024 - 2027 |
Country | Northern Ireland |
PhD Title | Non-viral genetic engineering of immune cells for CAR therapies |
Name | Zixu Liu |
Years of Study | 2025 - 2028 |
Country | China |